These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21800357)

  • 21. Impact of novel agents followed by autologous hematopoietic stem cell transplantation for multiple myeloma patients aged 65 years or older: a retrospective single Institutional analysis.
    Minoia C; Pisapia G; Palazzo G; Ingrosso C; Buonanno M; Spinosa C; Prudenzano A; Pricolo G; Mazza P
    Bone Marrow Transplant; 2015 Nov; 50(11):1486. PubMed ID: 26281030
    [No Abstract]   [Full Text] [Related]  

  • 22. High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma.
    Awedan AA
    Ann Transplant; 2002; 7(2):38-43. PubMed ID: 12416471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial treatment of transplant candidates with multiple myeloma.
    Moreau P; Touzeau C
    Semin Oncol; 2013 Oct; 40(5):585-91. PubMed ID: 24135403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kidney Transplantation for Kidney Failure Due to Multiple Myeloma: Case Reports.
    Le TX; Wolf JL; Peralta CA; Webber AB
    Am J Kidney Dis; 2017 Jun; 69(6):858-862. PubMed ID: 28320553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support.
    Iversen PO; Wisløff F; Gulbrandsen N
    Clin Nutr; 2010 Aug; 29(4):488-91. PubMed ID: 20044183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of interferon in the treatment of multiple myeloma].
    Shimazaki C
    Nihon Rinsho; 2006 Jul; 64(7):1291-6. PubMed ID: 16838647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple myeloma in 2020: state of the art.
    Cerchione C; Martinelli G
    Panminerva Med; 2020 Dec; 62(4):191-192. PubMed ID: 32957745
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiple myeloma. Progress is being made.
    Mayo Clin Health Lett; 2011 Mar; 29(3):4-5. PubMed ID: 21553706
    [No Abstract]   [Full Text] [Related]  

  • 29. Complete remission of multiple myeloma.
    Lonial S
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):671-2, 675. PubMed ID: 17982407
    [No Abstract]   [Full Text] [Related]  

  • 30. Testicular invading refractory multiple myeloma during bortezomib treatment successfully treated with lenalidomide: a case report.
    Miyao K; Sakemura R; Sakai T; Tsushita N; Kato T; Niimi K; Ono Y; Sawa M
    Ann Hematol; 2014 Mar; 93(3):529-30. PubMed ID: 23820941
    [No Abstract]   [Full Text] [Related]  

  • 31. Transplantation in multiple myeloma.
    Topolsky D; Biggs D
    Semin Oncol; 1995 Jun; 22(3):230-7. PubMed ID: 7777867
    [No Abstract]   [Full Text] [Related]  

  • 32. Recent phase III trials in the frontline treatment of multiple myeloma: evaluating their impact on community practice.
    SanMiguel J; Facon T; Cavo M
    Clin Adv Hematol Oncol; 2008 Apr; 6(4):s4-s10. PubMed ID: 18567204
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of multiple myeloma with interferon].
    Bruno S
    Medicina (B Aires); 1996; 56 Suppl 1():92-4. PubMed ID: 9224981
    [No Abstract]   [Full Text] [Related]  

  • 34. Modern treatment options for elderly patients with multiple myeloma.
    Görner M; Späth-Schwalbe E;
    Onkologie; 2008 Jun; 31(6):335-42. PubMed ID: 18547977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Standard therapy for multiple myeloma].
    Tokuhira M; Kizaki M
    Rinsho Ketsueki; 2012 Oct; 53(10):1675-88. PubMed ID: 23037740
    [No Abstract]   [Full Text] [Related]  

  • 36. Stevens-Johnson/toxic epidermal necrolysis overlap syndrome following lenalidomide treatment for multiple myeloma relapse after allogeneic transplantation.
    Wäsch R; Jakob T; Technau K; Finke J; Engelhardt M
    Ann Hematol; 2012 Feb; 91(2):287-9. PubMed ID: 21494796
    [No Abstract]   [Full Text] [Related]  

  • 37. Induction therapy in multiple myeloma.
    Harousseau JL
    Hematology Am Soc Hematol Educ Program; 2008; ():306-12. PubMed ID: 19074101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.
    Kröger N; Zabelina T; Ayuk F; Atanackovic D; Schieder H; Renges H; Zander A
    Exp Hematol; 2006 Jun; 34(6):770-5. PubMed ID: 16728282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response evaluation and monitoring of multiple myeloma.
    Fernández de Larrea C; Delforge M; Davies F; Bladé J
    Expert Rev Hematol; 2014 Feb; 7(1):33-42. PubMed ID: 24483347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple myeloma.
    Raab MS; Podar K; Breitkreutz I; Richardson PG; Anderson KC
    Lancet; 2009 Jul; 374(9686):324-39. PubMed ID: 19541364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.